{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/68083-173#drug","name":"Deferoxamine mesylate","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"68083-173"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA207384"},{"@type":"PropertyValue","propertyID":"UNII","value":"V9TKO7EO6K"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"598fba68-f46e-4b6e-894c-63c2940b2063"}],"activeIngredient":"DEFEROXAMINE MESYLATE","administrationRoute":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"dosageForm":"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Gland Pharma Limited"},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA207384","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=598fba68-f46e-4b6e-894c-63c2940b2063","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68083-173"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T14:32:56.379Z"}}